cp bebe- glycerin lotion
recell u korea - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - glycerin 3 g in 100 ml - skin protectant apply proper amount to the skin
cp medi theraphy- glycerin gel
recell u korea - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - glycerin 0.2 g in 100 ml - skin protectant apply proper amount to the skin
cp medi- glycerin cream
recell u korea - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - glycerin 6 g in 100 ml - skin protectant apply proper amount to the skin
cp bebe wash- glycerin shampoo
recell u korea - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - glycerin 0.001 g in 100 ml - skin protectant apply proper amount to the skin
vancocin cp 1g powder for injection
aspen pharmacare australia pty ltd - vancomycin, quantity: 1 g (equivalent: vancomycin, qty 1 million iu) - injection, powder for - excipient ingredients: disodium edetate; sodium hydroxide; hydrochloric acid - indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (eg e faecalis), only in combination with an aminoglycoside. for the treatment of diphtheroid endocarditis. in combination with rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids. in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. wh
vancocin cp 500mg powder for injection
aspen pharmacare australia pty ltd - vancomycin, quantity: 500 mg (equivalent: vancomycin, qty 500000 iu) - injection, powder for - excipient ingredients: disodium edetate; hydrochloric acid; sodium hydroxide - indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (eg e faecalis), only in combination with an aminoglycoside. for the treatment of diphtheroid endocarditis. in combination with rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids. in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. wh
eimeria maxima cp
intervet australia pty limited - eimeria maxima cp - unknown - eimeria maxima cp vaccine-general active 0.0 - active constituent
cp stent - prosthesis, internal, stent, vascular
intervene medical pty ltd - 36035 - prosthesis, internal, stent, vascular - an expandable "zig" pattern stent to establish and maintain the patency of the aorta
cp pharma diphenhydramine expectorant
hovid berhad - diphenhydramine hydrochloride; ammonium chloride; sodium citrate/trisodium citrate -
cp pharma paracetamol oral suspension 250mg5ml
hovid berhad - paracetamol -